Titan Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Titan Pharmaceuticals Inc cash flow-to-debt ratio. Titan Pharmaceuticals Inc (TTNP) has a Cash Flow-to-Debt Ratio of -2.59x as of June 2025, meaning its operating cash flow of $-680.00K could theoretically repay -3% of its total liabilities ($263.00K) in one year. Check how high is Titan Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Titan Pharmaceuticals Inc (1995–2024)
Cash flow-to-debt ratio of Titan Pharmaceuticals Inc from 1995 to 2024. Historical debt coverage capacity for Titan Pharmaceuticals Inc across 30 annual periods. Check TTNP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Titan Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (1995–2024)
Titan Pharmaceuticals Inc cash flow-to-debt ratio by year from 1995 to 2024. Year-by-year debt coverage analysis for Titan Pharmaceuticals Inc. For the full cash flow conversion analysis, see Titan Pharmaceuticals Inc (TTNP) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -8.03x | $-3.88 Million | $483.00K | ▼ -63.6% |
| 2023 | -4.91x | $-7.09 Million | $1.44 Million | ▼ -61.8% |
| 2022 | -3.04x | $-8.18 Million | $2.69 Million | ▼ -9.8% |
| 2021 | -2.77x | $-7.90 Million | $2.86 Million | ▲ +26.8% |
| 2020 | -3.78x | $-17.20 Million | $4.55 Million | ▼ -97.8% |
| 2019 | -1.91x | $-15.45 Million | $8.09 Million | ▼ -64.5% |
| 2018 | -1.16x | $-8.43 Million | $7.26 Million | ▲ +28.4% |
| 2017 | -1.62x | $-13.04 Million | $8.05 Million | ▼ -241.0% |
| 2016 | 1.15x | $6.29 Million | $5.48 Million | ▲ +196.9% |
| 2015 | -1.19x | $-7.47 Million | $6.30 Million | ▼ -147.4% |
| 2014 | -0.48x | $-5.87 Million | $12.24 Million | ▲ +38.1% |
| 2013 | -0.77x | $-9.80 Million | $12.66 Million | ▼ -2127.8% |
| 2012 | 0.04x | $1.83 Million | $47.95 Million | ▲ +108.0% |
| 2011 | -0.48x | $-14.48 Million | $30.30 Million | ▼ -10.9% |
| 2010 | -0.43x | $-4.66 Million | $10.80 Million | ▲ +68.6% |
| 2009 | -1.37x | $-5.41 Million | $3.93 Million | ▲ +78.8% |
| 2008 | -6.50x | $-25.34 Million | $3.90 Million | ▼ -82.1% |
| 2007 | -3.57x | $-15.19 Million | $4.26 Million | ▲ +10.3% |
| 2006 | -3.98x | $-13.50 Million | $3.39 Million | ▲ +45.6% |
| 2005 | -7.31x | $-22.92 Million | $3.14 Million | ▼ -12.2% |
| 2004 | -6.51x | $-23.91 Million | $3.67 Million | ▲ +17.7% |
| 2003 | -7.91x | $-26.44 Million | $3.34 Million | ▼ -6.6% |
| 2002 | -7.42x | $-29.29 Million | $3.94 Million | ▼ -211.5% |
| 2001 | -2.38x | $-13.74 Million | $5.76 Million | ▲ +55.4% |
| 2000 | -5.34x | $-13.16 Million | $2.46 Million | ▲ +6.8% |
| 1999 | -5.74x | $-10.90 Million | $1.90 Million | ▲ +29.9% |
| 1998 | -8.19x | $-13.10 Million | $1.60 Million | ▼ -930.3% |
| 1997 | 0.99x | $7.10 Million | $7.20 Million | ▲ +134.7% |
| 1996 | -2.84x | $-10.80 Million | $3.80 Million | ▼ -207.3% |
| 1995 | -0.92x | $-8.60 Million | $9.30 Million | — |